chang
follow
infect
central
clinic
manifest
diseas
howev
inform
regard
chang
anim
diseas
limit
canin
parvoviru
infect
puppi
measur
level
acut
phase
protein
chang
leukocyt
phenotyp
cell
trafick
flow
cytometri
paramet
correl
convent
assess
clinic
diseas
vaccin
eficaci
studi
importantli
acut
phase
protein
becam
elev
lymphopenia
neutropenia
modul
detect
control
vaccin
elsevi
scienc
ltd
type
describ
new
canin
pathogen
howev
new
strain
quickli
emerg
today
common
europ
repres
cu
current
field
isol
unit
state
puppi
viru
replic
mitot
cell
j
transmit
fecalor
rout
caus
fulmin
enter
diseas
initi
infect
like
occur
tonsil
howev
viru
rapidli
spread
lymphoid
tissu
crypt
cell
gut
crypt
cell
death
eros
enter
line
result
vomit
diarrhea
characterist
diseas
protect
young
puppi
mainli
passiv
transfer
matern
antibodi
offspr
howev
matern
antibodi
declin
puppi
becom
highli
suscept
infect
suscept
parvoviru
infect
often
coincid
time
puppi
separ
dam
significantli
increas
risk
exposur
clinic
sign
result
experiment
challeng
strain
typic
mild
repres
virul
diseas
observ
natur
infect
strain
preval
unit
state
lymphopenia
usual
evalu
manual
differenti
cell
count
highli
variabl
neutropenia
commonli
describ
natur
case
inconsist
observ
experiment
challeng
central
research
diyis
pfizer
inc
eastern
point
road
groton
ct
usa
correspond
address
receiv
juli
revis
octob
accept
octob
vaccin
volum
number
paramet
reduct
viral
shed
proven
use
assess
vaccin
efficaci
understand
abil
evalu
clinic
diseas
constantli
chang
technolog
reagent
develop
exampl
flow
cytometri
util
frequent
diagnost
situat
cell
specif
quantit
data
regard
cell
popul
combin
autom
total
white
cell
count
inform
may
yield
power
less
variabl
analysi
cell
surfac
protein
leukocyt
traffick
similarli
acut
phase
respons
well
known
nonspecif
respons
pathogen
despit
nonspecif
natur
respons
recent
evid
shown
stimulu
product
acut
phase
protein
liver
tightli
regul
respons
cytokin
ill
releas
soon
addit
productlon
specif
antibodi
reagent
foster
develop
quantit
assay
increas
accuraci
specif
detect
acut
phase
reactant
thu
elev
level
one
proinflammatori
protein
may
predict
clinic
infect
diseas
elev
level
ul
acid
glycoprotein
al
ag
serum
amyloid
saa
describ
associ
acut
well
chronic
diseas
impact
vaccin
paramet
infecti
challeng
examin
studi
evalu
whether
measur
level
acut
phase
protein
investig
chang
leukocyt
phenotyp
flow
cytometri
would
complement
convent
clinic
assess
vaccin
efficaci
studi
associ
paramet
major
clinic
sign
parvoviru
induc
diseas
vaccin
vs
nonvaccin
anim
describ
seroposit
puppi
given
vaccin
follow
experiment
infect
specif
emphasi
place
measur
cpv
specif
neutral
antibodi
two
acut
phase
reactant
saa
chang
associ
leukopenia
character
use
flow
cytometr
analysi
sixweekold
mongrel
puppi
alder
ridg
farm
bwef
inc
lakewood
pa
matern
deriv
serum
neutral
sn
titer
rang
use
fifti
puppi
random
two
treatment
group
base
sex
litter
date
birth
group
similar
rang
sn
titer
puppi
vaccin
subcutan
week
age
experiment
parvoviru
modifiedl
vaccin
titer
log
tcid
ml
parvoviru
compon
deliv
combin
distemperadenoviru
type
kill
corona
viru
leptospira
canicolaicterohaemorrhagia
bacterin
pfizer
inc
lincoln
ne
placebo
consist
earl
balanc
salt
solut
biowhittak
walkersvil
md
given
subcutan
control
group
order
simul
statu
nonvaccin
puppi
field
serum
sampl
collect
prior
first
vaccin
week
interv
antibodi
titer
serial
twofold
dilut
heat
inactiv
serum
sampl
made
microtit
plate
sampl
incub
tcid
j
viru
min
dog
kidney
cell
x
per
well
ad
incub
three
day
plate
contain
viru
cell
control
visual
viru
infect
cell
monolay
fix
aceton
react
monoclon
antibodi
mab
loooo
specif
major
capsid
protein
vpl
follow
fluorescein
conjug
antimurin
igg
kierkegaard
perri
intern
gaithersburg
md
well
consid
posit
viru
three
three
cell
focu
fluoresc
endpoint
neutral
titer
determin
reciproc
final
serum
dilut
one
less
one
two
well
less
three
posit
cell
obtain
nation
veterinari
servic
laboratori
ame
ia
challeng
dose
studi
determin
given
oral
intranas
tcid
per
dose
week
age
clinic
score
base
clinic
attitud
normal
moribund
euthanasia
death
observ
vomit
food
mucu
mucu
dehydr
slightl
qualiti
fece
form
form
form
form
blood
nonform
nonform
nonform
blood
signific
clinic
score
calcul
mean
plu
day
score
puppi
puppi
observ
day
postchalleng
howev
clinic
sign
rectal
bodi
temperatur
score
first
day
moribund
anim
human
euthan
observ
period
attend
veterinarian
fecal
sampl
collect
daili
day
postchalleng
store
isol
replic
viru
sampl
prepar
clarifi
wv
fecal
suspens
tissu
cultur
medium
duplic
tenfold
dilut
suspens
mix
felin
kidney
cell
x
cell
per
well
microtit
plate
incub
day
cell
monolay
fix
stain
major
capsid
protein
specif
mab
describ
viru
titer
calcul
use
spearmankarb
equat
log
titer
tcid
ml
level
sensit
assay
due
fecal
sampl
toxic
score
viru
shed
peripher
blood
leukocyt
pbl
edta
collect
day
postchalleng
sampl
divid
two
aliquot
one
submit
commerci
laboratori
roch
diagnost
burlington
nc
total
leukocyt
count
cell
differenti
analysi
process
flow
cytometri
pbl
wash
free
serum
flow
buffer
hank
balanc
salt
solut
biowhittak
without
phenol
red
mg
contain
sodium
azid
bsa
fraction
v
sigma
chemic
co
st
loui
mo
pbl
resuspend
origin
volum
flow
buffer
cell
react
optim
dilut
unconjug
murin
mab
specif
canin
antibodi
specif
follow
canin
leukocyt
subset
use
tcell
lsm
gml
neutrophilsl
monocyt
vmrd
pullman
wa
specif
bind
detect
use
fluorescein
fitc
conjug
goat
f
ab
antimurin
igg
igm
antibodi
biosourc
intern
camarillo
ca
previous
adsorb
canin
spleen
aceton
powder
sigma
control
well
contain
unstain
cell
cell
react
fitc
antibodi
alon
erythrocyt
remov
fac
lyse
solut
bectondickinson
mountain
view
ca
cell
fix
use
pformaldehyd
flow
buffer
store
data
acquir
ungat
cell
use
facstar
plu
bectondickinson
flow
cytomet
analyz
use
pc
lysi
j
bectondickinson
softwar
logic
gate
drawn
around
lymphocyt
monocyt
neutrophil
popul
base
forward
side
light
scatter
profil
use
side
scatter
vs
fluoresc
intens
marker
fluores
intens
set
base
neg
control
sampl
discount
erythrocyt
lysi
incomplet
signific
contamin
lymphocyt
gate
prevent
accur
analysi
absolut
lymphocyt
count
flow
cytometr
analyz
leukocyt
calcul
use
total
leukocyt
count
obtain
commerci
multipli
percentag
deriv
flow
cytometr
analysi
pant
cell
plu
cell
plu
b
cell
percentag
compar
cell
count
obtain
manual
differenti
obtain
commerci
commerci
avail
canin
specif
radial
immunodiffus
kit
development
technolog
frederick
md
use
accord
manufactur
specif
control
standard
test
serum
plasma
sampl
pipet
precut
well
gel
impregn
canin
antibodi
h
room
temperatur
humid
chamber
area
within
precipitin
ring
measur
use
bioimag
gel
scanner
millipor
corpor
bedford
quantiti
test
sampl
extrapol
control
standard
includ
plate
level
saa
quantit
sandwich
elisa
use
two
mab
specif
differ
epitop
canin
saa
saa
captur
onto
well
elisa
plate
one
mab
detect
biotinyl
second
mab
amplif
strepavidinhorseradish
peroxidas
antibodi
assay
develop
laboratori
dr
thoma
l
saa
standard
determin
sequenc
analysi
amino
acid
composit
sever
protein
copurifi
canin
saa
render
standard
protein
determin
inaccur
sensit
assay
rang
pg
ml
inter
intra
experiment
variat
peripher
blood
lymphocyt
drawn
prechalleng
day
puppi
use
establish
normal
valu
hematolog
measur
upper
lower
cutoff
valu
signific
determin
group
mean
sd
differ
group
evalu
use
fisher
exact
test
pvalu
twosid
test
ltest
squar
root
transform
valu
pvalu
base
cochran
cox
approxim
differ
group
varianc
statist
correl
evalu
spearman
rank
method
nonparametr
seroconvers
vaccin
seroposit
puppi
determin
fourfold
increas
sn
titer
previou
timepoint
prior
challeng
vaccin
puppi
seroconvert
howev
occur
differ
timepoint
three
dose
vaccin
regimen
figur
sn
titer
prior
first
vaccin
continu
drop
rang
time
second
vaccin
fourfold
increas
titer
observ
third
vaccin
postchalleng
sn
titer
three
puppi
among
lowest
puppi
control
group
challeng
develop
sever
sign
consist
vomit
diarrhea
depress
anorexia
dehydr
contrast
mild
symptom
typic
elicit
experiment
challeng
normal
mean
clinic
score
day
f
elev
clinic
score
observ
begin
day
peak
mean
day
postchalleng
figur
fourteen
puppi
die
euthan
observ
period
contrast
occasion
observ
mild
gastrointestin
upset
result
elev
clinic
score
given
vaccin
puppi
howev
sign
accompani
depress
anorexia
dehydr
viru
shed
fever
consist
find
elev
temperatur
c
observ
vaccin
control
singl
day
one
puppi
control
group
experienc
three
consecut
day
fever
none
vaccin
puppi
shed
detect
level
replic
viru
stage
day
observ
period
figur
zb
contrast
nonvaccin
control
shed
viru
begin
day
peak
titer
day
postchalleng
surviv
puppi
still
shed
signific
level
viru
day
postchalleng
day
post
challeng
elev
al
ag
twoto
fivefold
saa
observ
figur
figur
nonvaccin
control
respect
begin
day
peak
day
post
challeng
normal
mean
plasma
level
saa
pg
ml
pg
ml
respect
level
elev
three
vaccin
day
postchalleng
similarli
saa
level
elev
two
vaccin
prior
challeng
low
signific
saa
valu
observ
three
vaccin
sporad
day
postchalleng
valu
coincid
clinic
sign
viru
shed
hematolog
chang
one
puppi
die
day
elev
level
either
acut
phase
reactant
clinic
score
significantli
correl
saa
day
similarli
day
use
cell
specif
antibodi
flow
cytometr
analysi
mean
leukocyt
peripher
day
post
challeng
blood
posit
identifi
tcell
cd
pant
bcell
monocyt
neutrophil
compar
absolut
leukocyt
count
obtain
convent
consist
fact
antibodi
natur
killer
cell
basophil
eosinophil
avail
commerci
lymphopenia
drop
initi
lymphocyt
count
identifi
puppi
control
group
vaccin
puppi
primarili
day
postchalleng
figur
flow
cytometr
analysi
peripher
blood
lymphopenia
due
loss
cell
b
cell
select
cell
cd
ratio
remain
constant
data
shown
comparison
use
manual
differenti
cell
count
control
vaccin
puppi
lymphopen
postchalleng
shown
neutrophilia
increas
prechalleng
absolut
neutrophil
count
observ
total
nonvaccin
control
day
vaccin
day
postchalleng
flow
cytometr
convent
differenti
count
percent
neutrophilia
control
higher
vaccin
day
neutropenia
observ
vaccin
day
observ
period
howev
manual
differenti
compar
flow
cytometri
nonvaccin
control
neutrophilia
follow
although
flow
cytometr
differenti
cell
count
less
variabl
day
day
basi
timepoint
obtain
manual
account
discrep
two
method
postchalleng
novel
chang
occur
pattern
express
neutrophil
compar
lymphocyt
normal
express
equal
bright
homogen
neutrophil
lymphocyt
determin
ratio
mean
fluoresc
intens
neutrophil
lymphocyt
nonvaccinatesl
f
vaccin
f
illustr
figur
az
howev
begin
day
postchalleng
intens
express
neutrophil
gradual
decreas
day
period
chang
bright
homogen
pattern
smear
cell
rang
dim
bright
anim
becam
complet
neg
chang
illustr
repres
histogram
repres
control
puppi
figur
ratio
mean
channel
fluoresc
intens
neutrophil
lymphocyt
drop
control
vaccin
remain
constant
global
downmodul
cell
surfac
protein
neutrophil
express
protein
bound
gml
antibodi
present
neutrophil
remain
constant
throughout
studi
figur
illustr
chang
express
neutrophil
percentag
neutrophil
whose
level
lymphocyt
record
timepoint
everi
anim
figur
signific
differ
level
neutrophil
lymphocyt
demonstr
control
one
vaccin
anim
begin
day
neutrophil
express
nonvaccin
control
statist
differ
vaccin
pooool
day
postchalleng
reduc
level
neutrophil
day
neg
correl
statist
signific
clinic
score
r
viru
shed
day
postchalleng
studi
clearli
demonstr
inform
obtain
measur
nonspecif
product
inflamm
leukocyt
traffick
flow
cytometri
effect
complement
tradit
method
vaccin
efficaci
assess
crucial
success
studi
determin
whether
paramet
correl
tradit
sign
clinic
diseas
thu
necessari
challeng
viru
use
experi
elicit
sever
clinic
sign
allow
clear
associ
nontradit
paramet
clinic
sign
viru
shed
elev
saa
level
occur
time
puppi
develop
clinic
sign
viru
appear
fece
furthermor
quantiti
saa
measur
individu
sampl
correl
sever
clinic
sign
viru
shed
peak
level
coincid
drop
total
leukocyt
day
one
puppi
elev
level
either
saa
postchalleng
puppi
die
day
postchalleng
show
sign
infect
ie
lymphopenia
viru
shed
drop
express
two
puppi
delay
respons
viru
challeng
show
clinic
sign
day
postchalleng
viru
shed
begin
day
time
saa
level
becam
elev
thu
instanc
elev
product
acut
phase
protein
close
follow
appear
viru
shed
fece
develop
clinic
sign
everyth
consid
data
demonstr
challeng
elev
product
saa
well
chang
express
correl
provid
quantifi
indic
viru
infect
clinic
diseas
lymphopenia
neutropenia
import
hematolog
chang
describ
natur
infect
canin
parvoviru
strong
correl
diseas
outcom
sever
neutropenia
observ
experiment
infect
lymphopenia
commonli
document
neutropenia
inconsist
demonstr
instanc
laboratori
assess
chang
manual
differenti
count
inher
variabl
subject
studi
demonstr
use
antibodi
flow
cytometr
analysi
posit
identifi
crucial
cell
popul
accur
less
variabl
depict
leukocyt
traffick
obtain
flow
cytometr
analysi
lymphopenia
document
major
control
none
vaccin
furthermor
abl
demonstr
neutropenia
follow
neutrophilia
signific
number
control
pattern
observ
vaccin
anim
thu
methodolog
accur
portray
clinic
pictur
commonli
seen
natur
infect
studi
natur
infect
direct
indirect
effect
cpv
neutrophil
examin
neutropenia
attribut
exhaust
neutrophil
result
secondari
bacteri
observati
on
made
present
studi
signific
therefor
demonstr
cpv
infect
produc
phenotyp
traffick
chang
neutrophil
neutropenia
occur
data
suggest
impair
neutrophil
function
occur
direct
indirect
effect
cpv
infect
cpv
may
predispos
factor
secondari
bacteri
infect
puppi
chang
appear
canin
neutrophil
puzzl
commonli
found
subset
cell
cell
particip
cell
signal
antigen
canin
relat
carnivor
uniqu
compar
mammalian
speci
neutrophil
well
cell
subset
express
high
level
protein
known
function
neutrophil
signific
chang
level
neutrophil
express
diseas
unknown
howev
chang
express
cell
traffick
neutrophil
observ
cpv
challeng
implic
role
cell
pathogenesi
cpv
diseas
signific
chang
emphas
consid
alter
express
observ
viral
infect
vaccin
protect
effect
also
noteworthi
among
paramet
evalu
studi
loss
express
one
consist
find
occur
nonvaccin
control
one
vaccin
sever
possibl
could
account
loss
neutrophilianeutropenia
pattern
observ
control
one
possibl
direct
effect
cpv
infect
bone
marrow
neutrophil
precursor
matur
chang
homeostasi
may
result
export
immatur
neutrophil
support
claim
neutrophilia
present
time
express
low
howev
visual
cell
differenti
analysi
reveal
increas
immatur
band
neutrophil
account
observ
neutrophilia
neutrophilia
observ
sever
vaccin
absenc
thu
chang
phenotyp
traffick
may
indirect
effect
viru
infect
destruct
gut
crypt
cell
releas
lp
bacteri
product
known
induc
ill
tnfa
tumor
necrosi
factoralpha
il
ill
known
induc
neutrophilia
synergi
tnf
induc
chang
vascular
endothelium
result
regul
cell
receptor
respons
cell
neutrophil
chemotact
factor
activ
recruit
neutrophil
site
tissu
damag
perhap
draw
bone
marrow
reserv
matur
neutrophil
postul
matur
bone
marrow
deriv
neutrophil
examin
may
present
lower
quantiti
circul
neutrophil
account
chang
express
observ
regardless
kinet
modul
traffick
argu
viru
secondari
infect
effect
chang
furthermor
chang
may
clue
indic
pathogen
insult
neutrophil
function
vaccin
experiment
vaccin
effect
stimul
sn
respons
puppi
sinc
respons
measur
strain
support
previou
data
indic
contain
neutral
epitop
import
note
seroconvers
occur
differ
point
three
dose
regimen
necessarili
correl
preexist
titer
three
puppi
sero
vaccin
volum
number
convert
third
vaccin
one
puppi
sn
titer
increas
experiment
infect
nonetheless
anim
remain
normal
exhibit
hematolog
chang
viru
shed
fece
observ
signific
individu
may
repres
minor
popul
sn
low
respond
suggest
local
cell
mediat
immun
may
suffici
develop
signific
immun
protect
summari
studi
inflammatori
event
result
parvoviru
infect
identifi
quantit
nontradit
paramet
complement
tradit
method
evalu
vaccin
efficaci
success
demonstr
puppi
vaccin
cpv
seroposit
protect
inflammatori
clinic
consequ
parvoviru
infect
virul
challeng
